Filing Details
- Accession Number:
- 0001209191-17-007809
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-03 18:21:40
- Reporting Period:
- 2017-02-02
- Filing Date:
- 2017-02-03
- Accepted Time:
- 2017-02-03 18:21:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1412067 | Cascadian Therapeutics Inc. | CASC | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1188919 | W Ted Love | C/O Cascadian Therapeutics, Inc. 2601 Fourth Ave., Suite 500 Seattle WA 98121 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-02-02 | 23,000 | $4.24 | 27,209 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Represents the weighted average sales price per share. The shares sold at prices ranging from $4.21 to $4.31 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer.
- Effective as of November 29, 2016, the issuer effected a 6-for-1 reverse split of its common stock. The number of shares above reflects the reverse stock split.
Billionaire Hedge Funds
